L 30 Therapy of CKD Flashcards

1
Q

What is chronic kidney Disease?

A

Abnormalities in the structure or function of the kidney
More than 3 months or more suffering with this condition
It is a progressive disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors for renal disease PROGRESSION?

A
  • proteinuria
  • elevated blood pressure
  • hyperglycaemia
  • hyperlipidaemia
  • AKI
  • smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is Chronic Kidney Disease diagnosed?

A
Detected by screening
Structural abnormalities (histology, albuminuria,albumin)
Functional abnormalities (GFR less than 60ml)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Signs and symptoms of CKD

A

Subtle and slow onset with no noticeable symptoms until later stages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Epidemiology of CKD?

A

Maori with increased age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Goals of CKD treatment

A

Prevent or slow the progress of CKD
Decrease CKD complications
Decrease CVD risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lab result for CKD is

A

Normal GFR is 90 or above L/min
Mild CKD GFR 60-90 ml/min
Moderate CKD is GFR 30-60 ml/min
Severe GFR 15-30 ml/Min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

During CKD progressions what are the 2 main functions that become impaired?

A

Excretory function i.e.water,waste etc

Regulatory function i,e. Extracellular fluid volume, electrolyte imbalance, pH etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Signs and symptoms of CKD in stage 4 and 5?

A

Severe renal impairment in stage 4 and 5 usually causes pruritus, taste disturbance, nausea vomiting, muscle pain, fatigue, bleeding etc.
And lab investigation report

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is renoprotection achieved in CKD?

A

Treatment of comorbidities
Managing complications
Renoprotection using ACEIs and ARBs to slow down progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the drugs of choice in diabetic and non-diabetic CKD?

A
\+2x example for each
ACEI (e.g enalapril, quinapril)
ARBs (e.g candesartan, losartan)
Risk factors for CKD and CKD progression
Age, hypertension, diabetes, dyslipidemia, glomerulonephritis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the non pharmacological treatment option for CKD?

A
Dietary sodium restriction 
Protein restriction 
Weight reduction 
Regular physical activity 
Moderate alcohol consumption 
Stop smoking or smoking cessation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What drugs are part of the triple whammy?

A
Which is the worst offender when added?
What is the triple whammy MoA?
ACEI/ARB + Diuretics + NSAID
NSAID = worst offender
- ACEI/ARB = vasodilation = reduced GFR
- Diuretics = reduce ECF volume
- NSAIDs = afferent arteriolar vasoconstriction = reduces BP and GFR = dangerous ontop of the other 2.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Consequence of triple whammy

A

Increased AKI risk of ~30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

At risk patients for triple whammy

A

Volume depleted patients, elderly, patients with heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management of triple whammy combinations

A

Not adding an NSAID - remind patients about OTCs

If necessary, monitor GFR and fluid status.

17
Q

QUIZ: ARBs reduce proteinuria by which of the following mechanisms?

A
  1. B2 receptor activation leading to decreased renin release.
  2. Inhibition of aldosterone binding to mineralocorticoid receptor.
  3. Vasodilation of efferent arterioles leading to reduced GFR and reduced proteinuria
    ARBS act by:
  4. Vasodilation of efferent arterioles leading to reduced GFR and reduced proteinuria
    Using ACEI and ARBs, what is the target urine albumin reduction in CKD?
    30-50%
18
Q

ACEI and ARBs can cause a…. therefore need to…

A

ACEI and ARBs can cause an initial 25% GFR reduction after starting the therapy initiation, therefore need to start low and titrate the dose, as well as monitor sCr, BP, and electrolytes to ensure GFR is not too impacted.

19
Q

Important side effects of ACEI and ARBs in CKD

A

Hyperkalaemia
Acute renal impairment
Dry cough (ACE, common)
Angioedema (rare but serious)

20
Q

As renal function declines, what kicks into gear and increases

A

RAAS system kicks into gear and renin increases, therefore ATII also increases

21
Q

What does an increase in ATII cause?

A

Vasoconstriction = increased glomerular pressure = maintains GFR BUT pushes more protein through the pores.

22
Q

What causes ACE?

A

Cause vasodilation of the different arterioles, as a result, reduces GFR rate.

23
Q

WHat NSAIDS do in kidney disease?

A

Vasoconstriction in the arteriole thus reduces blood flow to the nephron result reduces GFR

24
Q

What diuretics reduce kidney disease?

A

Reduces extracellular fluid volume

25
Q

What happens when protein is pushed through the pores? What does this do?

A

Proteinuria/albuminuria causes nephron loss, increasing kidney disease, and CV mortality

26
Q

What is the MoA or proteinuria?

A

Proteins are reabsorbed in the renal tubules, activating inflammatory cytokines causing interstitial damage and damaging nephrons.